drugset / Trial / NCT03513406
Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to learn if there is a difference in recovery time when using sugammadex versus neostigmine. The researchers also hope to add further knowledge and data to the safety of using sugammadex in burn patients who are hypermetabolic.
Timeline
- Start
- 2018-03-15
- Primary completion
- 2023-03-07
- Completion
- 2023-03-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Neostigmine | Other / unclassified | 50 ug/kg | Intravenous |
| Comparator | Sugammadex | Other / unclassified | 2 mg/kg | Intravenous |
| Comparator | Glycopyrrolate | Small molecule | 10 ug/kg | Intravenous |
Indications
No indication recorded.